Probiotic and Oxytocin Combination Therapy in Patients with Autism Spectrum Disorder: A Randomized, Double-Blinded, Placebo-Controlled Pilot Trial

Autism spectrum disorder (ASD) is a rapidly growing neurodevelopmental disorder. Both probiotics and oxytocin were reported to have therapeutic potential; however, the combination therapy has not yet been studied. We conducted a randomized, double-blinded, placebo-controlled, 2-stage pilot trial in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Xue-Jun, Liu, Jun, Liu, Kevin, Koh, Madelyn, Sherman, Hannah, Liu, Siyu, Tian, Ruiyi, Sukijthamapan, Piyawat, Wang, Jiuju, Fong, Michelle, Xu, Lei, Clairmont, Cullen, Jeong, Min-Seo, Li, Alice, Lopes, Maria, Hagan, Veronica, Dutton, Tess, Chan, Suk-Tak (Phoebe), Lee, Hang, Kendall, Amy, Kwong, Kenneth, Song, Yiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147925/
https://www.ncbi.nlm.nih.gov/pubmed/34062986
http://dx.doi.org/10.3390/nu13051552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147925/
https://www.ncbi.nlm.nih.gov/pubmed/34062986
http://dx.doi.org/10.3390/nu13051552

Ejemplares similares